{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1235.329",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-06-16T01:00:56.000-04:00",
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablevalueset",
    "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString" : "B.well Connected Health Author"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate" : "2023-06-16"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate" : "2023-06-16"
  }],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1235.329"
  }],
  "version" : "20230616",
  "name" : "HighRiskHPVTest_HD_HCPCS",
  "title" : "High Risk HPV Test_HD_HCPCS",
  "status" : "active",
  "date" : "2023-06-16T01:00:56-04:00",
  "publisher" : "B.well Connected Health Steward",
  "description" : "b.well created value set by Sr. Clinical Business Analyst for High Risk HPV Test.",
  "jurisdiction" : [{
    "extension" : [{
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
      "valueString" : "UNKNOWN"
    }]
  }],
  "purpose" : "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute High Risk HPV Test for inclusion and utilization in patients/users connected heath.),(Data Element Scope: High Risk HPV Test for b.well.),(Inclusion Criteria: High Risk HPV Test Codes that constitute a Cancer Care Need for b.well.),(Exclusion Criteria: N/A)",
  "compose" : {
    "include" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "concept" : [{
        "code" : "G0476",
        "display" : "Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:ff6667f7-ba25-4d15-b03b-5907d037f375",
    "timestamp" : "2023-09-26T10:50:56-04:00",
    "total" : 1,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "version" : "2023",
      "code" : "G0476",
      "display" : "Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test"
    }]
  }
}